Clinical Trial of Maternal Choline Supplements to Mitigate Effects of Prenatal Cannabis Exposure on Early Brain Development
Primary Objective
The purpose of the study is to see if a dietary supplement helps improve early brain development in fetuses of pregnant women who use cannabis products.
Description
Have an in-person appointment every six weeks and a telephone call every two weeks starting around 16-weeks gestation up until birth. Take the study supplement by mouth every morning and evening until birth. Have 5 in-person appointments and once monthly telephone calls about your child’s development from birth until your child is 2. Have 4 in-person appointments and 4 phone calls between your child’s 2nd and 4th birthdays.To make sure you're eligible, we may review your UCHealth medical record. You will be compensated for your participation.
Details
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Camille Hoffman-Shuler
Study ID
Protocol Number: 23-2327
More information available at ClinicalTrials.gov: NCT06379971
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers